Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1992 1
1994 2
1995 12
1996 5
1997 1
1998 1
1999 2
2000 3
2001 1
2002 1
2003 3
2004 3
2005 3
2006 2
2007 2
2008 14
2009 7
2010 8
2011 7
2012 8
2013 6
2014 4
2015 1
2016 4
2017 4
2018 5
2019 4
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
Ravaud A, Motzer RJ, Pandha HS, George DJ, Pantuck AJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Martini JF, Ramaswamy K, Casey M, Staehler M, Patard JJ; S-TRAC Investigators. Ravaud A, et al. Among authors: pandha hs. N Engl J Med. 2016 Dec 8;375(23):2246-2254. doi: 10.1056/NEJMoa1611406. Epub 2016 Oct 9. N Engl J Med. 2016. PMID: 27718781 Free article. Clinical Trial.
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.
Motzer RJ, Ravaud A, Patard JJ, Pandha HS, George DJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Casey M, Serfass L, Pantuck AJ, Staehler M. Motzer RJ, et al. Among authors: pandha hs. Eur Urol. 2018 Jan;73(1):62-68. doi: 10.1016/j.eururo.2017.09.008. Epub 2017 Sep 28. Eur Urol. 2018. PMID: 28967554 Free PMC article. Clinical Trial.
PBX3 in Cancer.
Morgan R, Pandha HS. Morgan R, et al. Among authors: pandha hs. Cancers (Basel). 2020 Feb 13;12(2):431. doi: 10.3390/cancers12020431. Cancers (Basel). 2020. PMID: 32069812 Free PMC article. Review.
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer.
Annels NE, Mansfield D, Arif M, Ballesteros-Merino C, Simpson GR, Denyer M, Sandhu SS, Melcher AA, Harrington KJ, Davies B, Au G, Grose M, Bagwan I, Fox B, Vile R, Mostafid H, Shafren D, Pandha HS. Annels NE, et al. Among authors: pandha hs. Clin Cancer Res. 2019 Oct 1;25(19):5818-5831. doi: 10.1158/1078-0432.CCR-18-4022. Epub 2019 Jul 4. Clin Cancer Res. 2019. PMID: 31273010 Free article. Clinical Trial.
Targeting HOX/PBX dimers in cancer.
Morgan R, El-Tanani M, Hunter KD, Harrington KJ, Pandha HS. Morgan R, et al. Among authors: pandha hs. Oncotarget. 2017 May 9;8(19):32322-32331. doi: 10.18632/oncotarget.15971. Oncotarget. 2017. PMID: 28423659 Free PMC article. Review.
Kinase Regulation of HOX Transcription Factors.
Primon M, Hunter KD, Pandha HS, Morgan R. Primon M, et al. Among authors: pandha hs. Cancers (Basel). 2019 Apr 10;11(4):508. doi: 10.3390/cancers11040508. Cancers (Basel). 2019. PMID: 30974835 Free PMC article. Review.
Tumour markers.
Pandha HS, Waxman J. Pandha HS, et al. QJM. 1995 Apr;88(4):233-41. QJM. 1995. PMID: 7540924 Review.
Tumour markers.
Pandha HS, Waxman J, Sikora K. Pandha HS, et al. Br J Hosp Med. 1994 Mar 16-Apr 5;51(6):297-303. Br J Hosp Med. 1994. PMID: 8032568 Review.
107 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page